@article{TEXTUAL,
      recid = {11222},
      author = {Patel, Manali I. and Ferguson, Jacqueline M. and Castro,  Eida and Pereira-Estremera, Cristina D. and Armaiz-Peña,  Guillermo N. and Duron, Ysabel and Hlubocky, Fay and  Infantado, Analynn and Nuqui, Bles and Julian, Donna and  Nortey, Nii and Steck, Alexandra and Bondy, Melissa and  Maingi, Shail},
      title = {Racial and Ethnic Disparities in Cancer Care During the  COVID-19 Pandemic},
      journal = {JAMA Network Open},
      address = {2022-07-14},
      number = {TEXTUAL},
      abstract = {&lt;p&gt;Importance: The full effect of the COVID-19 pandemic on  cancer care disparities, particularly by race and  ethnicity, remains unknown.&lt;/p&gt;&lt;p&gt;Objectives: To assess  whether the race and ethnicity of patients with cancer was  associated with disparities in cancer treatment delays,  adverse social and economic effects, and concerns during  the COVID-19 pandemic and to evaluate trusted sources of  COVID-19 information by race and ethnicity.&lt;/p&gt;&lt;p&gt;Design,  Setting, and Participants: This national survey study of US  adults with cancer compared treatment delays, adverse  social and economic effects, concerns, and trusted sources  of COVID-19 information by race and ethnicity from  September 1, 2020, to January 12, 2021. Exposures: The  COVID-19 pandemic.&lt;/p&gt;&lt;p&gt;Main Outcomes and Measures: The  primary outcome was delay in cancer treatment by race and  ethnicity. Secondary outcomes were duration of delay,  adverse social and economic effects, concerns, and trusted  sources of COVID-19 information.&lt;/p&gt;&lt;p&gt;Results: Of 1639  invited respondents, 1240 participated (75.7% response  rate) from 50 US states, the District of Columbia, and 5 US  territories (744 female respondents [60.0%]; median age, 60  years [range, 24-92 years]; 266 African American or Black  [hereafter referred to as Black] respondents [21.5%]; 186  Asian respondents [15.0%]; 232 Hispanic or Latinx  [hereafter referred to as Latinx] respondents [18.7%]; 29  American Indian or Alaska Native, Native Hawaiian, or  multiple races [hereafter referred to as other] respondents  [2.3%]; and 527 White respondents [42.5%]). Compared with  White respondents, Black respondents (odds ratio [OR], 6.13  [95% CI, 3.50-10.74]) and Latinx respondents (OR, 2.77 [95%  CI, 1.49-5.14]) had greater odds of involuntary treatment  delays, and Black respondents had greater odds of treatment  delays greater than 4 weeks (OR, 3.13 [95% CI, 1.11-8.81]).  Compared with White respondents, Black respondents (OR,  4.32 [95% CI, 2.65-7.04]) and Latinx respondents (OR, 6.13  [95% CI, 3.57-10.53]) had greater odds of food insecurity  and concerns regarding food security (Black respondents:  OR, 2.02 [95% CI, 1.34-3.04]; Latinx respondents: OR, 2.94  [95% CI, [1.86-4.66]), financial stability (Black  respondents: OR, 3.56 [95% CI, 1.79-7.08]; Latinx  respondents: OR, 4.29 [95% CI, 1.98-9.29]), and  affordability of cancer treatment (Black respondents: OR,  4.27 [95% CI, 2.20-8.28]; Latinx respondents: OR, 2.81 [95%  CI, 1.48-5.36]). Trusted sources of COVID-19 information  varied significantly by race and  ethnicity.&lt;/p&gt;&lt;p&gt;Conclusions and Relevance: In this survey  of US adults with cancer, the COVID-19 pandemic was  associated with treatment delay disparities and adverse  social and economic effects among Black and Latinx adults.  Partnering with trusted sources may be an opportunity to  overcome such disparities.&lt;/p&gt;},
      url = {http://knowledge.uchicago.edu/record/11222},
}